The past year has proven that innovations in drug product technology can be implemented faster, to the benefit of patients. The focus of this webinar is manufacturing speed and agility, standardization and the rewards and risks of technology adoption. Our panel of experts will share their experiences and key considerations for the future of drug product operations.
Matthew has 25 years of biopharmaceutical industry experience with multiple operating companies. At the Center for Breakthrough Medicines at the Discovery Labs, he is responsible for establishing the critical support services necessary for laboratory and manufacturing operations, including technical engineering support for process operations and facility design. Previously, Matthew was Senior Project Manager with CRB Consulting Engineers, where he led engineering design projects with specific focus on biopharmaceutical and advanced technology facilities and operations. Matthew is the Past President of Delaware Valley Chapter of ISPE, and remains an engaged member of the industry professional society. He holds a Bachelor of Science in chemical engineering from Drexel University.
Gary has over 32 years of experience in the design, development, technical transfer and commercialization of aseptic and purification processes associated with the production of biopharmaceuticals. To date, he has contributed to the successful commercialization of four biologics, two complex generics, one imaging contrast agent and one reusable auto-injector device for prefilled syringes. Gary is currently responsible for the oversight of parenteral drug product manufacturing at GSK’s contract manufacturing organizations, including management of technology transfer, scale-up, process optimization and trouble-shooting, and validation activities.
Brent is the Senior Director of Operations at Singota Solutions. He has nearly 30 years in the pharmaceutical industry, from API manufacture through aseptic filling to final drug product packaging, in operations ranging from small clinical to large commercial scale production. His contributions in multiple start-ups have included technology transfer, equipment selection and validation, regulatory submission preparation, and managing both regulatory and client inspections. Brent has strengths in continuous improvement, process optimization, and cross-function/facility harmonization. He received his Bachelor of Science from Pepperdine University.
Arsalan Arif is a news media entrepreneur who set out in 2015 to build his vision of an independent biotech news company at Endpoints News.